Apart from the characterization of the Philadelphia chromosome in the CML, the discovery of the JAK2 V617F mutation in 2005 [[5],[6]] is the most thrilling development in the molecular diagnosis of Ph-negative MPNs. This evidence concerns the gene JAK2 and chronic myelogenous leukemia, BCR-ABL1 positive.